TUB Share Price Performance
€166.80
40.20 (31.75%)
Price €166.80
Share Price€166.80
TUB Community Narratives
There are no narratives available yet.
Recent TUB News & Updates
Financière de Tubize SA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 21, 2026
- Earnings per share (EPS)
- 2.08
- Gross Margin
- -19,655.96%
- Net Profit Margin
- 699,544.01%
- Debt/Equity Ratio
- 0%
Financière de Tubize SA Competitors
Snowflake Analysis
About TUB
- Founded
- 1928
- Employees
- n/a
- CEO
- WebsiteView website
Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affects immune system or central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium.
Market Insight
Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading
Belgian Market Performance
- 7 Days: -0.7%
- 3 Months: 0.7%
- 1 Year: 5.3%
- Year to Date: 8.7%
The Healthcare sector gained 4.5% while the market remained flat over the last week. As for the longer term, the market has risen 5.3% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›